While I agree that it won't do much in terms of moving the needle on the share price, I have to believe this is somewhat invaluable information for Dr. JL and crew. Anecdotal or not, if the mouse study shows good results and they somewhat mimic what happens with Dr. Chan then that gives them a data point in a human subject that shows results that they had hoped to see. Likewise, if the mouse trial is ambiguous and it doesn't appear to do much for Dr. Chan then perhaps they steer the ship away and spend resources on something more promising.